According to the American Cancer Society, in the United States, over 153,000 new cases of colorectal cancer will be reported in 2007 and over 52,000 people will die from that disease. Colorectal cancer is the third most common cause of cancer death in both men and women. The ability to detect early metabolic changes with positron emission tomography (PET) has impacted the management of patients with this disease. In this program, we explore the impact of positron emission tomography/computed tomography (PET/CT) imaging in the diagnosis, staging, and treatment of patients with colorectal cancer.
To find out if your facility has a subscription or to get information on how to become a subscriber, please contact us at email@example.com or call 1800 659 465.